118 related articles for article (PubMed ID: 16466700)
41. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
[TBL] [Abstract][Full Text] [Related]
42. Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II.
Stavropoulou V; Xie J; Henriksson M; Tomkinson B; Imreh S; Masucci MG
Cancer Res; 2005 Feb; 65(4):1361-8. PubMed ID: 15735022
[TBL] [Abstract][Full Text] [Related]
43. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
44. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
Sekhon HS; London CA; Sekhon M; Iversen PL; Devi GR
Lung Cancer; 2008 Jun; 60(3):347-54. PubMed ID: 18096271
[TBL] [Abstract][Full Text] [Related]
45. [Study of Shuangling Fuzheng anti-tumor preparation on proliferation and c-myc gene expression of SGC-7901 cells].
Chen HS; Xu AH; Jia LC; Ren L
Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(21):1822-4. PubMed ID: 17260804
[TBL] [Abstract][Full Text] [Related]
46. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
Kluiver J; van den Berg A; de Jong D; Blokzijl T; Harms G; Bouwman E; Jacobs S; Poppema S; Kroesen BJ
Oncogene; 2007 May; 26(26):3769-76. PubMed ID: 17173072
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
[TBL] [Abstract][Full Text] [Related]
48. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
49. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
50. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.
Xie XK; Yang DS; Ye ZM; Tao HM
Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985
[TBL] [Abstract][Full Text] [Related]
51. Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein.
Fest T; Guffei A; Williams G; Silva S; Mai S
Oncogene; 2005 Apr; 24(18):2944-53. PubMed ID: 15735723
[TBL] [Abstract][Full Text] [Related]
52. All-trans retinoic acid induces Thrombospondin-1 expression in acute promyelocytic leukemia cells though down-regulation of its transcription repressor, c-MYC oncoprotein.
Xu B; Liu P; Li J; Lu H
Biochem Biophys Res Commun; 2009 May; 382(4):790-4. PubMed ID: 19324018
[TBL] [Abstract][Full Text] [Related]
53. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.
Sundberg TB; Ney GM; Subramanian C; Opipari AW; Glick GD
Cancer Res; 2006 Feb; 66(3):1775-82. PubMed ID: 16452238
[TBL] [Abstract][Full Text] [Related]
54. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.
Efferth T; Benakis A; Romero MR; Tomicic M; Rauh R; Steinbach D; Häfer R; Stamminger T; Oesch F; Kaina B; Marschall M
Free Radic Biol Med; 2004 Oct; 37(7):998-1009. PubMed ID: 15336316
[TBL] [Abstract][Full Text] [Related]
56. Pisosterol induces interphase arrest in HL60 cells with c-MYC amplification.
Silva TC; Lima PD; Bahia MO; Khayat AS; Bezerra FS; Andrade-Neto M; Seabra AD; Pontes TB; Moraes MO; Montenegro RC; Costa-Lotufo LV; Pessoa C; Pinto GR; Burbano RR
Hum Exp Toxicol; 2010 Mar; 29(3):235-40. PubMed ID: 20071475
[TBL] [Abstract][Full Text] [Related]
57. [Mechanisms of dibutyl phthalate to purge leukemic cells].
Wan WQ; Liu XY; Deng B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):79-80. PubMed ID: 16137013
[TBL] [Abstract][Full Text] [Related]
58. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.
Molina-Privado I; Rodríguez-Martínez M; Rebollo P; Martín-Pérez D; Artiga MJ; Menárguez J; Flemington EK; Piris MA; Campanero MR
Cancer Res; 2009 May; 69(9):4052-8. PubMed ID: 19406837
[TBL] [Abstract][Full Text] [Related]
59. Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphoma.
Boffa LC; Cutrona G; Cilli M; Mariani MR; Matis S; Pastorino M; Damonte G; Millo E; Roncella S; Ferrarini M
Oligonucleotides; 2005; 15(2):85-93. PubMed ID: 15989423
[TBL] [Abstract][Full Text] [Related]
60. Granulocytic differentiation of HL-60 cells, both spontaneous and drug-induced, might require loss of extrachromosomal DNA encoding a gene(s) not c-MYC.
Haque MM; Hirano T; Nakamura H; Utiyama H
Biochem Biophys Res Commun; 2001 Nov; 288(3):586-91. PubMed ID: 11676483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
